Shares of Invuity Inc (NASDAQ:IVTY) have earned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $4.25.
Several research firms recently issued reports on IVTY. Leerink Swann cut Invuity from an “outperform” rating to a “market perform” rating in a research report on Wednesday, September 12th. ValuEngine raised Invuity from a “sell” rating to a “hold” rating in a report on Wednesday, September 12th. Stifel Nicolaus cut Invuity from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Piper Jaffray Companies cut Invuity from an “overweight” rating to a “neutral” rating in a report on Tuesday, September 11th. Finally, Northland Securities cut Invuity from an “outperform” rating to a “market perform” rating in a report on Monday, September 17th.
IVTY stock opened at $7.39 on Friday. Invuity has a 12-month low of $2.35 and a 12-month high of $9.55.
Invuity, Inc, a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities.
Featured Story: How do candlesticks reflect price movement?
Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.